Skip to main content
. Author manuscript; available in PMC: 2014 Aug 25.
Published in final edited form as: JAMA Ophthalmol. 2013 Jul;131(7):870–879. doi: 10.1001/jamaophthalmol.2013.2313

Table 1.

Baseline and Outcome Diabetic Macular Edema Definitions in Time Domain Optical Coherence Tomography Images

Follow up Macular Edema
Categories
Definition
Baseline DME Categories

A. No central involved DME and
no non-central involved DME
CSF<190¦ for women or CSF<210¦ for men, and all ISF<260, and all OSF<220
B. No central involved DME and
definite or possible if non-central
involved DME
CSF <190¦ for women or CSF<210¦ for men, and at least 1 ISF >260 or OSF>220
C. possible if central involved
DME and no non-central involved
DME
CSF 190¦ to 249¦¦ for women or CSF 210¦ to 249¦¦ for men, and all ISF <260, and all
OSF<220
D. Possible if central involved
DME and definite or possible if
non-central involved DME
CSF 190¦ to 249¦¦ for women or CSF 210 to 249¦¦ for men, and at least 1 ISF >260 or
OSF>220

Central-Involved Macular
Edema at Follow Up
Study eye meeting any one of the following:
  1. CSF thickness ≥250* μ at 16 weeks and increased at least 1 logOCT unit from baseline to 16 weeks

  2. CSF thickness increased at least 2 logOCT units from baseline to 16 weeks

  3. Any treatment for DME or CME other than topical medications was received after surgery, and criterion (1) or (2) was met prior to starting treatment


Development or
Progression of Non-central-
Involved Macular Edema at
Follow Up
Study eye meeting any one of the following:
  1. At least 1 ISF ≥310 microns at 16 weeks and the corresponding ISF increased at least 1 log unit from baseline to 16 weeks OR at least 1 OSF ≥290†† microns at 16 weeks and the corresponding OSF increased at least 1 logOCT unit from baseline to 16 weeks

  2. At least 1 ISF increased at least 2 logOCT units from baseline to 16 weeks OR at least 1 OSF increased at least 2 logOCT units from baseline to 16 weeks

  3. Any treatment for DME or CME other than topical drops was received after surgery, and criterion (1) or (2) was met prior to starting treatment

DME=diabetic macular edema; CSF=central subfield; ISF=inner subfields; OSF=outer subfields;; CME=cystoids macular edema

*

310 on spectral domain machines

356, 369, and 348 on the spectral domain machines Zeiss Cirrus, Heidelberg Spectralis and Optovue RTVue respectively. Values represent mean+2 standard deviations from a normal cohort of the ISFs of respective machines.

††

303, 322, and 307 on the spectral domain machines Zeiss Cirrus, Heidelberg Spectralis and Optovue RTVue respectively. Values represent mean+2 standard deviations of the OSFs of respective machines.

¦

Women: 250, 260, and 240; Men: 260, 280, and 240 on the spectral domain machines Zeiss Cirrus, Heidelberg Spectralis and Optovue RTVue respectively.

¦¦

309 on the on the spectral domain machines Zeiss Cirrus, Heidelberg Spectralis and Optovue RTVue

260, 260, 340 on the spectral domain machines Zeiss Cirrus, Heidelberg Spectralis and Optovue RTVue respectively.

260, 220, and 290 on the spectral domain machines Zeiss Cirrus, Heidelberg Spectralis and Optovue RTVue respectively.